Dr. Tamas Gonda values the privilege of getting to know his patients, developing relationships based on trust, and helping them feel better. In addition to treating illness, his goal and passion, both in clinical practice and research, is the prevention of disease, particularly cancer prevention. Dr. Gonda specializes in gastroenterology and treats patients with diseases of the pancreas or bile duct, ranging from benign conditions to cancer. He also manages precancerous and malignant diseases of the esophagus, stomach, and colon. At NYU Langone’s Tisch Hospital, Dr. Gonda serves as the chief of endoscopy and director of the Pancreatic Disease Program. He is experienced in advanced endoscopy techniques and procedures used to manage a variety of diseases in the upper and lower esophageal tract, including early detection of precancerous lesions, endoscopic tumor removal, and treatment of malignant diseases. Pancreatic diseases, such as pancreatitis, pancreatic cystic lesions, and pancreatic cancer, are a focus of his clinical practice.
Dr. Gonda is particularly skilled in managing complex pancreatic and bile duct diseases, including acute and chronic pancreatitis and bile duct obstruction. One of his goals is to offer patients treatments that require minimal intervention or disruption to their lives. Recent innovations in thermal ablation and radiofrequency ablation to shrink tumors without needing removal are areas of great promise and interest to him. At NYU Langone, Dr. Gonda is part of a multidisciplinary team that integrates gastroenterology and therapeutic endoscopy with surgery, radiology, oncology, and other medical specialties to provide the best treatment options and high-quality care to patients. He strongly believes that offering a balanced and detailed view of the risks and benefits of each treatment option is critical in patient care. Dr. Gonda presents patients with data and recommendations from the team to guide them through the decision-making process, ensuring they can select the best approach together.
The Pancreatic Disease Program is one example where he strives to deliver integrated, multidisciplinary care to patients in collaboration with the Pancreatic Cancer Center at Perlmutter Cancer Center. His research focuses on the biology, diagnosis, and treatment of pancreatic and bile duct diseases, including cancer. He is working to identify biomarkers to advance understanding of the biology of precancerous conditions, which could help improve diagnoses and identify various levels of risk for developing cancer. Additionally, he conducts research on endoscopic therapy for pancreatic cancer and the genetic changes that cause pancreatic and gastrointestinal cancer. Dr. Gonda has published more than 100 peer-reviewed articles in top-tier medical journals and authored textbook chapters. His work has been funded by multiple national societies and the National Institutes of Health. He is a fellow of the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy. In 2014, Dr. Gonda received the Landon Foundation–American Association for Cancer Research INNOVATOR Award for Cancer Prevention Research.